Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Montelukast in chronic obstructive pulmonary disease
IRCT20190423043361N1Phase 4Completed
- Sponsor
- Lorestan University of Medical Sciences
- Start
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in chronic obstructive pulmonary disease (COPD) comparing Montelukast with Placebo (2 arms). Primary endpoints: Serum TNF-alpha level, Serum C-reactive protein level and 1 more. Started Nov 2017; status: completed.
02
Drugs
montelukast
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on IRCT20190423043361N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190423043361N1.